Coherent: Lumentum Deal Is An Optics Networking Gift

Coherent is positioned to benefit from AI-driven optical-networking demand, with quarterly sales guided to grow from $2B in FQ4'26 to $3B by the end of FY27. The article says the Marvell-Lumentum merger could distract a key competitor for 18+ months, opening a strategic window for Coherent to win hyperscaler and CPO/NPO business. Analysts project FY28 EPS near $14.

Analysis

The investable question is whether COHR can convert capacity and product launches into qualified, repeatable hyperscaler revenue—not whether optical demand is strong. A competitor’s integration burden could create a temporary opening, but customer qualification cycles and second-sourcing requirements may limit how quickly that opening translates into shipments. If the article’s projected sales ramp materializes, monitor gross margin, yield, and cash conversion: a capacity build can lift revenue while depreciation, startup costs, or price competition dilute EPS.

Near term, sentiment may favor COHR, while LITE could face execution uncertainty tied to the proposed combination; MRVL should not be treated as a pure optical-comp exposure given its broader business. Over 1–3 months, order/qualification evidence and guidance revisions matter more than launch announcements. Over 6–18 months, CPO/NPO adoption and whether customers maintain multiple qualified suppliers will determine if the opportunity is durable or merely a share-timing benefit. The FY28 EPS figure is an estimate, not verified earnings power; valuation and the underlying margin bridge are missing, so avoid underwriting it without diligence.

Contrarian risk: the market may overvalue a competitor’s distraction while underweighting COHR’s own ramp execution and the possibility that hyperscalers retain LITE or other suppliers. Verify transaction status, customer wins, backlog conversion, capacity yields, and incremental margins before sizing aggressively.

Key Decisions for Investors

• Consider a modest relative-value position: long COHR / short LITE, sized to limit broad optical-sector exposure. Add only after COHR demonstrates order conversion and stable or improving gross margin; reduce if LITE’s integration proceeds smoothly or COHR misses its sales trajectory. Check valuation, borrow, and transaction exposure before entry.
• Treat COHR’s sales outlook and FY28 EPS estimate as a catalyst watch, not a base-case forecast. Seek confirmation in reported revenue, backlog conversion, customer qualification, gross margin, and cash flow; do not pay for the EPS estimate without a credible bridge from capacity to earnings.
• Key falsifiers: COHR cuts or fails to support its ramp outlook, margins weaken as capacity comes online, customer wins do not convert into shipments, or LITE shows no meaningful integration disruption. Reassess as well if CPO/NPO deployment is delayed or hyperscalers preserve existing supplier allocations.